CIK 0001830487
- Large accelerated filer
Pharvaris N.V.
Sign in to watch- Ticker
- PHVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- Other
- Phone
- +31 712036410
- Business address
- J.H. OORTWEG 21, 2333 CH LEIDEN, LEIDEN, Netherlands
- Former names
- Pharvaris, B.V.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,335,217
- in 16 filings, $4.1M under 10b5-1 plans
Net −$20,335,217. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Schikan Johannes Gerardus Christiaan Petrus −$7.0M Director sold 64% of stake
- Lu Peng −$4.7M President sold 67% of stake
- Bjork Elisabeth −$2.0M Director sold 78% of stake
- Lesage Anne −$1.9M Chief Early Development sold 40% of stake
- Abele Stefan Andreas −$1.8M Chief Technical Ops Officer sold 54% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-17 | Glassman Robert Director | Exercise or conversion | +14,493 | $18.14 | $263K | 24,993 |
| 2026-09-17 | Glassman Robert Director | Sale | −14,493 | $38.56 | $559K | 10,500 |
| 2026-09-17 | Glassman Robert Director | Exercise or conversion · Stock Option (Right to Buy) | −14,493 | 0 | ||
| 2026-09-15 | Glassman Robert Director | Exercise or conversion 10b5-1 | +8,667 | $22.31 | $193K | 19,167 |
| 2026-09-15 | Glassman Robert Director | Sale 10b5-1 | −8,667 | $38.27 | $332K | 10,500 |
| 2026-09-15 | Glassman Robert Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −8,667 | 0 | ||
| 2026-09-09 | Glassman Robert Director | Exercise or conversion 10b5-1 | +8,000 | $20.00 | $160K | 18,500 |
| 2026-09-09 | Glassman Robert Director | Sale 10b5-1 | −8,000 | $37.55 | $300K | 10,500 |
| 2026-09-09 | Glassman Robert Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −8,000 | 0 | ||
| 2026-05-15 | Glassman Robert Director | Exercise or conversion | +5,333 | $22.31 | $119K | 20,500 |
| 2026-05-15 | Glassman Robert Director | Sale | −5,333 | $29.83 | $159K | 15,167 |
| 2026-05-15 | Glassman Robert Director | Sale | −4,667 | $29.82 | $139K | 10,500 |
| 2026-05-15 | Glassman Robert Director | Exercise or conversion · Stock Option (Right to Buy) | −5,333 | 8,667 |
Page 1 of 1 · 13 trades